Total Payments
$13,517
2024 Payments
$201.99
Companies
17
Transactions
71
Medicare Patients
8,524
Medicare Billing
$455,262
Payment Breakdown by Category
Consulting$6,000 (44.4%)
Other$4,500 (33.3%)
Food & Beverage$2,473 (18.3%)
Travel$544.03 (4.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,000 | 1 | 44.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,500 | 1 | 33.3% |
| Food and Beverage | $2,473 | 65 | 18.3% |
| Travel and Lodging | $544.03 | 4 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lantheus Medical Imaging, Inc. | $11,866 | 21 | $0 (2022) |
| Astellas Pharma US Inc | $249.99 | 2 | $0 (2018) |
| Novo Nordisk Inc | $215.74 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $193.30 | 3 | $0 (2023) |
| Amgen Inc. | $179.88 | 7 | $0 (2024) |
| Philips Electronics North America Corporation | $176.98 | 2 | $0 (2022) |
| PFIZER INC. | $155.76 | 9 | $0 (2022) |
| Abbott Laboratories | $150.00 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $84.02 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $82.82 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $201.99 | 9 | Amgen Inc. ($86.09) |
| 2023 | $490.41 | 10 | Abbott Laboratories ($150.00) |
| 2022 | $327.23 | 11 | Philips Electronics North America Corporation ($102.25) |
| 2021 | $43.30 | 2 | Janssen Pharmaceuticals, Inc ($43.30) |
| 2020 | $10,626 | 3 | Lantheus Medical Imaging, Inc. ($10,626) |
| 2019 | $1,062 | 21 | Lantheus Medical Imaging, Inc. ($848.80) |
| 2018 | $455.91 | 10 | Lantheus Medical Imaging, Inc. ($186.84) |
| 2017 | $309.37 | 5 | Lantheus Medical Imaging, Inc. ($141.91) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $28.75 | General |
| 11/07/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $30.72 | General |
| 10/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $14.88 | General |
| 05/11/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: DIABETES | ||||||
| 02/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Diabetes | ||||||
| 01/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Diabetes | ||||||
| 10/12/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $30.62 | General |
| Category: Cardiovascular | ||||||
| 09/27/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Diabetes | ||||||
| 06/08/2023 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Vascular | ||||||
| 05/12/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Diabetes | ||||||
| 03/27/2023 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $25.38 | General |
| Category: Coronary | ||||||
| 03/11/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Diabetes | ||||||
| 02/22/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: Cardiology | ||||||
| 02/09/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/08/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Diabetes | ||||||
| 01/30/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $28.85 | General |
| Category: Cardiovascular | ||||||
| 12/01/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Diabetes | ||||||
| 11/10/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/10/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Diabetes | ||||||
| 10/28/2022 | Lantheus Medical Imaging, Inc. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: CONTRAST AGENT | ||||||
| 10/14/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Diabetes | ||||||
| 09/14/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,211 | 2,332 | $536,402 | $113,575 |
| 2022 | 16 | 2,175 | 2,279 | $514,525 | $113,150 |
| 2021 | 15 | 2,445 | 2,557 | $914,244 | $135,639 |
| 2020 | 14 | 1,693 | 1,737 | $608,112 | $92,898 |
Total Patients
8,524
Total Services
8,905
Medicare Billing
$455,262
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 825 | 845 | $211,250 | $48,333 | 22.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 168 | 171 | $159,030 | $29,790 | 18.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 111 | 112 | $34,720 | $7,357 | 21.2% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 78 | 158 | $12,324 | $5,315 | 43.1% |
| 78451 | Nuclear medicine study of heart muscle at rest and with stress and spect | Facility | 2023 | 92 | 92 | $23,920 | $4,821 | 20.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 218 | 219 | $19,710 | $3,902 | 19.8% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 52 | 52 | $17,160 | $3,800 | 22.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 38 | 38 | $17,860 | $3,530 | 19.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 218 | 219 | $13,140 | $2,609 | 19.9% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 143 | 144 | $15,408 | $1,491 | 9.7% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 92 | 92 | $6,440 | $1,439 | 22.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 24 | 28 | $2,800 | $596.16 | 21.3% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 115 | 119 | $1,190 | $315.06 | 26.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 23 | 27 | $810.00 | $167.44 | 20.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 14 | 16 | $640.00 | $109.95 | 17.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 813 | 851 | $212,750 | $51,379 | 24.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 144 | 146 | $135,780 | $26,683 | 19.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 96 | 96 | $29,760 | $6,329 | 21.3% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2022 | 63 | 63 | $20,790 | $4,492 | 21.6% |
| 78451 | Nuclear medicine study of heart muscle at rest and with stress and spect | Facility | 2022 | 79 | 79 | $20,540 | $4,339 | 21.1% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2022 | 56 | 114 | $8,892 | $4,088 | 46.0% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2022 | 38 | 39 | $18,330 | $3,759 | 20.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 206 | 206 | $18,540 | $3,725 | 20.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 206 | 206 | $12,360 | $2,470 | 20.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2022 | 101 | 102 | $7,140 | $1,593 | 22.3% |
About Dr. Lori Croft, MD
Dr. Lori Croft, MD is a Cardiovascular Disease healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336140631.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lori Croft, MD has received a total of $13,517 in payments from pharmaceutical and medical device companies, with $201.99 received in 2024. These payments were reported across 71 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($6,000).
As a Medicare-enrolled provider, Croft has provided services to 8,524 Medicare beneficiaries, totaling 8,905 services with total Medicare billing of $455,262. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location New York, NY
- Active Since 08/09/2005
- Last Updated 09/17/2009
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1336140631
Products in Payments
- DEFINITY (Drug) $10,688
- Definity (Drug) $1,178
- Ozempic (Drug) $198.00
- ELIQUIS (Drug) $196.15
- XARELTO (Drug) $193.30
- MITRACLIP (Device) $150.00
- (5044) MCOT (Device) $102.25
- ENTRESTO (Drug) $82.82
- Repatha (Biological) $75.13
- EPIQ 7C (Device) $74.73
- Corlanor (Drug) $45.28
- JARDIANCE (Drug) $42.44
- CAMZYOS (Drug) $28.85
- FFRct (Device) $25.38
- WATCHMAN (Device) $24.64
- Reveal LINQ (Device) $20.77
- MOUNJARO (Drug) $20.19
- Rybelsus (Drug) $17.74
- VYNDAQEL (Drug) $14.78
- SC2000 (Device) $13.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in New York
Dr. Roger Hajjar, Md, MD
Cardiovascular Disease — Payments: $5.2M
Cardiovascular Disease $5.2M
Dr. Jacob Koruth, M.d, M.D
Cardiovascular Disease — Payments: $3.2M
Cardiovascular Disease $3.2M
Dr. Martin Leon, M.d, M.D
Cardiovascular Disease — Payments: $2.7M
Cardiovascular Disease $2.7M
Dr. Gregg Stone, M.d, M.D
Cardiovascular Disease — Payments: $2.2M
Cardiovascular Disease $2.2M
Adam Rosenbluth, Md, MD
Cardiovascular Disease — Payments: $1.5M
Cardiovascular Disease $1.5M
Dr. Deepak Bhatt, Md, MD
Cardiovascular Disease — Payments: $1.4M
Cardiovascular Disease $1.4M